Multiple characteristic alterations and available therapeutic strategies of cellular senescence
- 17 February 2023
- journal article
- review article
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 24 (2) , 101-114
Abstract
Given its state of stable proliferative inhibition, cellular senescence is primarily depicted as a critical mechanism by which organisms delay the progressKeywords
This publication has 126 references indexed in Scilit:
- Synthetic lethal metabolic targeting of cellular senescence in cancer therapyNature, 2013
- A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescenceNature, 2013
- Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer ProgressionCancer Research, 2012
- Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivityGenes & Development, 2011
- The essence of senescence: Figure 1.Genes & Development, 2010
- p53 Regulates Hematopoietic Stem Cell QuiescenceCell Stem Cell, 2009
- Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory NetworkCell, 2008
- Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virusJournal of Experimental Medicine, 2008
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737Journal of Clinical Investigation, 2007